Team:LMU-Munich
From 2014.igem.org
Line 5: | Line 5: | ||
<script src="http://preview.c9.io/loxos/igemlmu/home.css"></script> | <script src="http://preview.c9.io/loxos/igemlmu/home.css"></script> | ||
<div id="home"> | <div id="home"> | ||
- | |||
<div id="home-logo"> | <div id="home-logo"> | ||
<a href="https://igem.org/Main_Page" target="_blank"> | <a href="https://igem.org/Main_Page" target="_blank"> | ||
Line 11: | Line 10: | ||
</a> | </a> | ||
</div> | </div> | ||
+ | <img id="skyline" src="https://static.igem.org/mediawiki/2014/9/97/LMU14_home_completeskyline.jpg"/> | ||
</div> | </div> | ||
<div id="lmu-content"> | <div id="lmu-content"> |
Revision as of 03:37, 18 October 2014
Increasing bacterial resistance to classical antibiotics remains a serious threat and urges the development of novel pathogen-killing strategies. Exploiting bacterial communication mechanisms such as quorum sensing is a promising strategy to specifically target certain pathogens. The major aim of this project is the introduction of a genetic circuit enabling Bacillus subtilis to actively detect, attach to, and eventually kill Staphylococcus aureus and Streptococcus pneumoniae.
Initially, we will introduce the autoinducer-sensing two-component systems of S. aureus and S. pneumoniae into B. subtilis. to create a pathogen-detecting strain. By utilizing quorum sensing-dependent promoters, we will then trigger pathogen-killing strategies like the production of antimicrobial peptides or biofilm degradation. As a safety measure a delayed suicide-switch guarantees non-persistence of genetically modified B. subtilis in the absence of pathogens. We envision the use of BaKillus as a smart, cheap and simple-to-use medical device for diagnostics and targeted treatment of multiresistant zupahbugs.